Shares of Evoke plc (LON:EVOK – Get Free Report) traded up 14.5% during mid-day trading on Thursday . The stock traded as high as GBX 48.90 ($0.64) and last traded at GBX 48.90 ($0.64). 42,064,105 shares were traded during trading, an increase of 1,236% from the average session volume of 3,148,381 shares. The stock had previously closed at GBX 42.70 ($0.56).
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group restated a “buy” rating and set a GBX 140 ($1.83) price objective on shares of Evoke in a report on Monday, December 16th.
View Our Latest Research Report on Evoke
Evoke Stock Performance
Evoke (LON:EVOK – Get Free Report) last posted its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Sell-side analysts predict that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Buying and Selling
In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average cost of GBX 70 ($0.92) per share, for a total transaction of £10,200.40 ($13,351.31). Also, insider Jonathan (Jon) Mendelsohn purchased 200,000 shares of the stock in a transaction that occurred on Monday, March 31st. The shares were acquired at an average cost of GBX 48 ($0.63) per share, for a total transaction of £96,000 ($125,654.45). 27.00% of the stock is currently owned by corporate insiders.
Evoke Company Profile
Further Reading
- Five stocks we like better than Evoke
- ETF Screener: Uses and Step-by-Step Guide
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- What is Forex and How Does it Work?
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- What Are Some of the Best Large-Cap Stocks to Buy?
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.